Sentence examples for control gist from inspiring English sources

This differential signaling suggests that both the identity and genotype of the oncogenic kinase control GIST pathology and may explain, in part, the biological heterogeneity of GISTs.

To ensure specificity of the antibody, appropriate controls, such as uterine tissue (negative control), GIST (characterized KIT positive case) from the clinical collaborators and commercially purchased normal meningeal tissue sections (BioChain, Hayward, CA, USA) were included for processing in each batch.

Cognitive control processes entailed in gist reasoning have been associated with frontal lobe networks and nodes within both the CEN and DMN (Nichelli et al. 1995; Chapman et al. 2005; Chen et al. 2006).

Control of the systemic GIST was temporarily lost on reduction of the dose of imatinib (due to limited drug supply) but on increasing the dose back to 800 mg per day, systemic disease was stabilized for a period of time before generalised progression occurred.

While Gist tightly controlled access to its product, the competition happily offered open access.

There were 48 matched (with regard to tumour size and Ki67 max %) historical controls of high-risk GIST with R0 resections, including 25 women and 23 men with a mean age of 67 years (s.d. 13, range 25 87 years).

He wanted to drive a fiendishly difficult course in Finland and he spent the first 45 minutes of the show gearing up for that task, by throwing a hideously overpowered Mini Metro around a track, learning to corner at speed in a Japanese supercar and getting the gist of throttle control on a motocross bike.

Seventy-one patients with gastric and 70 with small intestinal GIST comprised the control groups, selected according to the predefined parameters (age, tumour size, mitotic index and adjuvant imatinib treatment) (Fig   1, Table   1).

ACOSOG Z9000 addresses treatment with imatinib (400 mg day−1 p.o. (orally)) for 1 year in patients with high-risk GIST with no control arm, while ACOSOG Z9001 compares imatinib treatment with placebo in patients with tumours ⩾3 cm (low, intermediate, and high-risk tumours).

26 After rapid development, it is today the first-line reference treatment in advanced GISTs, achieves disease control in 70%–85% of patients with a median progression-free survival (PFS) of 20 24 months and a median overall survival (OS) of 50 55 months.

Both DMN and CEN networks have been identified as integrated functional hubs that mediate higher order cognitive control processes such as embodied in gist reasoning.